{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:19:51Z","timestamp":1791937191419,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd011209","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000}}],"reference-count":79,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011209.pub2","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T13:03:21Z","timestamp":1421067801000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Nortriptyline for neuropathic pain in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Sheena","family":"Derry","sequence":"first","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Aldington","sequence":"additional","affiliation":[{"name":"Royal Hampshire County Hospital; Winchester UK SO22 5DG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD011209.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5414\/CPP44358","article-title":"Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial","volume":"44","author":"Chandra","year":"2006","journal-title":"International journal of Clinical Pharmacology and Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD011209.pub2-BIB0002|cit2","first-page":"544","article-title":"Combined treatment with gabapentin and nortriptyline improves pain control in peripheral neuropathy more than either agent alone","volume":"16","author":"Block","year":"2009","journal-title":"Journal of Clinical Outcomes Management"},{"issue":"9697","key":"10.1002\/14651858.CD011209.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0140-6736(09)61081-3","article-title":"Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial","volume":"374","author":"Gilron","year":"2009","journal-title":"Lancet"},{"issue":"1-2","key":"10.1002\/14651858.CD011209.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0304-3959(02)00047-7","article-title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy","volume":"98","author":"Hammack","year":"2002","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD011209.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1990.tb01584.x","article-title":"A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain","volume":"82","author":"Panerai","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0304-3959(85)90010-7","article-title":"Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study","volume":"23","author":"G\u00f3mez-P\u00e9rez","year":"1985","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0009|cit9","first-page":"525","article-title":"Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy","volume":"27","author":"G\u00f3mez-P\u00e9rez","year":"1986","journal-title":"Archives of Medical Research"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0010|cit10","unstructured":"Phase III randomized controlled study of morphine and nortriptyline in the management of postherpetic neuralgia clinicaltrials.gov\/ct2\/show\/NCT00004390?term=NCT00004390&rank=1 (accessed 10 June 2014)"},{"issue":"7","key":"10.1002\/14651858.CD011209.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0012|cit12","unstructured":"Chisholm C (Principle investigator) High versus low dose Nortriptyline for pain control and sleep in the presence of radicular back pain www.anzctr.org.au\/ACTRN12612001304820.aspx (accessed 1 July 2014)"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0013|cit13","unstructured":"Gilron I (Principle investigator) A double-blind, randomised controlled trial of nortriptyline, morphine, and their combination for neuropathic pain www.controlled-trials.com\/ISRCTN04803491 (accessed 1 July 2014)"},{"issue":"9","key":"10.1002\/14651858.CD011209.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":"EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision","volume":"17","author":"Attal","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD011209.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0018|cit18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003226.pub2","article-title":"Anticonvulsant drugs for migraine prophylaxis","author":"Chronicle","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD011209.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub3","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011209.pub2-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6 Suppl63","key":"10.1002\/14651858.CD011209.pub2-BIB0022|cit22","first-page":"S110","article-title":"Pharmacological treatment of fibromyalgia","volume":"28","author":"Franco","year":"2010","journal-title":"Clinical and experimental Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2006.10.001","article-title":"Sodium channel blockade may contribute to the analgesic efficacy of antidepressants","volume":"8","author":"Dick","year":"2007","journal-title":"Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85(3 Suppl)","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"issue":"5","key":"10.1002\/14651858.CD011209.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010769.pub2","article-title":"Imipramine for neuropathic pain in adults","author":"Hearn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0030|cit30","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota,1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011209.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archinte.1996.00440060089011","article-title":"The importance of quality of primary studies in producing unbiased systematic reviews","volume":"156","author":"Khan","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"1-3","key":"10.1002\/14651858.CD011209.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0039|cit39","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0040|cit40","article-title":"Chronic Pain","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011209.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.neuroimage.2007.03.054","article-title":"Brain imaging of neuropathic pain","volume":"37","author":"Moisset","year":"2007","journal-title":"Neuroimaging"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0043|cit43","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD011209.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011209.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD011209.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0058|cit58","unstructured":"NICE clinical guideline 173 Neuropathic pain - pharmacological management www.nice.org.uk\/guidance\/CG173 (accessed 24 March 2014) 2013 1 138"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011209.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"10 Suppl","key":"10.1002\/14651858.CD011209.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.04.007","article-title":"Treatment of neuropathic pain: an overview of recent guidelines","volume":"122","author":"O'Connor","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(92)90144-Z","article-title":"Antidepressant-induced analgesia in chronic non-malignant pain: a meta-analysis of 39 placebo-controlled studies","volume":"49","author":"Onghena","year":"1992","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0063|cit63","unstructured":"PaPaS author and referee guidance http:\/\/papas.cochrane.org\/papas-documents (accessed 22 January 2013)"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0064|cit64","volume-title":"Prescription cost analysis, England 2013","author":"Prescribing and Primary Care team","year":"2014"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0066|cit66","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"Epub ahead of p","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: A community-based study","volume":"April 1","author":"Soni","year":"2013","journal-title":"Arthritis & Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD011209.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia--responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011209.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrneurol.2011.4","article-title":"Can neuroimaging studies identify pain endophenotypes in humans?","volume":"7","author":"Tracey","year":"2011","journal-title":"Nature Reviews Neurology"},{"issue":"18","key":"10.1002\/14651858.CD011209.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Hecke","year":"2014","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011209.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD011209.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD011209.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011209.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011209.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T13:44:29Z","timestamp":1680183869000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011209.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011209.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]}}}